Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial

BACKGROUND: The prevalence of fibromyalgia increases worldwide and is characterized by widespread and chronic pain. Treatment is difficult and includes both drug and non-drug approaches. Milnacipran, an antidepressant, is used for fibromyalgia, with a possible beneficial effect on central pain modul...

Descripción completa

Detalles Bibliográficos
Autores principales: Macian, Nicolas, Pereira, Bruno, Shinjo, Coralie, Dubray, Claude, Pickering, Gisèle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393595/
https://www.ncbi.nlm.nih.gov/pubmed/25873248
http://dx.doi.org/10.1186/s13063-015-0659-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393595/
https://www.ncbi.nlm.nih.gov/pubmed/25873248
http://dx.doi.org/10.1186/s13063-015-0659-4

Ejemplares similares